Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

137 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pertuzumab: new hope for patients with HER2-positive breast cancer.
Capelan M, Pugliano L, De Azambuja E, Bozovic I, Saini KS, Sotiriou C, Loi S, Piccart-Gebhart MJ. Capelan M, et al. Among authors: bozovic i. Ann Oncol. 2013 Feb;24(2):273-282. doi: 10.1093/annonc/mds328. Epub 2012 Aug 21. Ann Oncol. 2013. PMID: 22910839 Free article. Review.
Genomic grade adds prognostic value in invasive lobular carcinoma.
Metzger-Filho O, Michiels S, Bertucci F, Catteau A, Salgado R, Galant C, Fumagalli D, Singhal SK, Desmedt C, Ignatiadis M, Haussy S, Finetti P, Birnbaum D, Saini KS, Berlière M, Veys I, de Azambuja E, Bozovic I, Peyro-Saint-Paul H, Larsimont D, Piccart M, Sotiriou C. Metzger-Filho O, et al. Among authors: bozovic i. Ann Oncol. 2013 Feb;24(2):377-384. doi: 10.1093/annonc/mds280. Epub 2012 Oct 1. Ann Oncol. 2013. PMID: 23028037 Free article.
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial.
Howard JF Jr, Bril V, Vu T, Karam C, Peric S, Margania T, Murai H, Bilinska M, Shakarishvili R, Smilowski M, Guglietta A, Ulrichts P, Vangeneugden T, Utsugisawa K, Verschuuren J, Mantegazza R; ADAPT Investigator Study Group. Howard JF Jr, et al. Lancet Neurol. 2021 Jul;20(7):526-536. doi: 10.1016/S1474-4422(21)00159-9. Lancet Neurol. 2021. PMID: 34146511 Clinical Trial.
Fatigue in myotonic dystrophy type 1: a seven-year prospective study.
Peric S, Bjelica B, Bozovic I, Pesovic J, Paunic T, Banovic M, Brkusanin M, Aleksic K, Basta I, Pavicevic DS, Stojanovic VR. Peric S, et al. Among authors: bozovic i. Acta Myol. 2019 Dec 1;38(4):239-244. eCollection 2019 Dec. Acta Myol. 2019. PMID: 31970322 Free PMC article.
Diabetes mellitus may affect short-term outcome of Guillain-Barré syndrome.
Peric S, Bozovic I, Bjelica B, Berisavac I, Stojiljkovic O, Basta I, Beslac-Bumbasirevic L, Rakocevic-Stojanovic V, Lavrnic D, Stevic Z. Peric S, et al. Among authors: bozovic i. J Peripher Nerv Syst. 2017 Jun;22(2):127-130. doi: 10.1111/jns.12206. J Peripher Nerv Syst. 2017. PMID: 28177572
137 results